Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.43% | 668.16% | 728.13% | 753.41% | 1,094.75% |
| Total Depreciation and Amortization | 51.06% | 44.57% | 7.82% | 1.35% | 4.09% |
| Total Amortization of Deferred Charges | 48.02% | 34.81% | 34.81% | 1,264.45% | 1,264.45% |
| Total Other Non-Cash Items | -347.22% | -26,401.35% | -6,851.57% | 628.73% | 428.96% |
| Change in Net Operating Assets | -1,026.78% | 1,083.44% | 485.25% | -4.27% | 349.73% |
| Cash from Operations | -123.71% | 653.01% | 834.35% | 1,220.23% | 1,666.12% |
| Capital Expenditure | -220.61% | -226.16% | -251.19% | -17.46% | 9.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.59% | 44.08% | 67.55% | 75.63% | -476.79% |
| Cash from Investing | 82.96% | 43.47% | 67.12% | 75.44% | -470.49% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -59.84% | -53.13% | -24.06% | 7.24% | 6.44% |
| Issuance of Common Stock | -13.27% | -99.34% | -99.43% | -99.63% | -99.59% |
| Repurchase of Common Stock | 14.94% | -15.61% | -15.61% | -15.61% | -643.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 99.96% | 98.95% |
| Cash from Financing | 9.67% | -106.33% | -104.84% | -105.02% | -107.10% |
| Foreign Exchange rate Adjustments | 209.28% | 5,891.87% | -965.26% | -1,285.65% | -6,043.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,569.28% | 1,316.99% | 4,965.12% | 43,574.84% | -98.86% |